EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

PAXLOVID – CONDITIONS OF USE - MEDICINAL PRODUCT FOR USE 1. Name of the medicinal product for use: PAXLOVID 2. Active substance(s): Nirmatrelvir and ritonavir 3. Pharmaceutical form: Film-coated tablets 4. Route of administration: Oral use 5. Strength: 150 mg Nirmatrelvir , 100 mg ritonavir
Pfizer boosts Paxlovid manufacturing capacity as Merck’s rival COVID pill hits surprise efficacy setback - The efficacy data for Pfizer’s oral COVID-19 drug now look so appealing that the Big Pharma company is boosting manufacturing capacity even before an expected emergency use authorization from the FDA. Pfizer now expects to make 80 million courses of COVID drug Paxlovid by the end of 2022, Pfizer CEO Albert Bourla told CNBC during […]
Local firms gear up to seek licence for Pfizer’s Covid drug - Synopsis: US drug giant Pfizer on Tuesday announced a deal with MPP – a UN-backed public health organization – to issue royalty-free voluntary licence to manufacture generic versions of oral antiviral Covid-19 medication Paxlovid in 95 middle and low income countries (LMIC) including India. After MSD’s molunpiravir, Indian drugmakers have now set their eyes on […]
Screening for SARS-CoV-2 non-structural protein 14 inhibitors - The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome generates 16 distinct non-structural proteins (nsp) that constitute the enzymes and accessory proteins responsible for virus replication once inside a host cell. These protein complexes produce and cap RNA strands that will go on to be translated by the host machinery. Capping the RNA in a […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us